{"groups":[{"description":"Mobilization with Filgrastim Stem Cell Collection (SCC) Bortezomib Melphalan Stem Cell infusion\n\nfilgrastim: 16 mcg/kg daily beginning 3 days before SCC through day before final SCC\n\nbortezomib: 1.0 mg/m2/dose D -6, D-3, D +1, D + 4\n\nmelphalan: 100 mg/m2/dose D -2, D -1\n\nStem Cell Infusion: infusion of previously collected autologous stem cells","id":"FG000","title":"SCT With Bortezomib and Melphalan"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"1"}],"type":"Adverse Event"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"10"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"9"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"1"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}